Show
Sort by
-
- Journal Article
- A1
- open access
Development and validation of a flow cytometry-based ISG15 induction assay to monitor the type I interferon response
-
- Journal Article
- A1
- open access
Clofazimine use for nontuberculous mycobacterial infections : 10-year experience in Belgium
-
- Journal Article
- A1
- open access
Physical activity and physical function one year after hospital discharge for COVID-19
-
- Journal Article
- A1
- open access
Use of inhaled corticosteroids in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)
-
- Journal Article
- A1
- open access
Objective sputum colour assessment and clinical outcomes in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)
-
- Journal Article
- A1
- open access
Bronchiectasis and asthma : data from the European Bronchiectasis Registry (EMBARC)
-
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
-
- Journal Article
- A1
- open access
Safety and outcomes of amikacin liposome inhalation suspension for Mycobacterium abscessus pulmonary disease : a NTM-NET
-
- Journal Article
- A1
- open access
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
-
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection